ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

Powers, NCI Still Disagree On Organ Systems Provisions

April 22, 1983

NCAB Subcommittee Oks Concept Of Five Recompetitions

October 23, 1981

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013